oxycodone has been researched along with Anoxia, Brain in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Afzal, A; Blough, BE; Bossert, JM; Epstein, DH; Fredriksson, I; Hoots, JK; Kiyatkin, EA; Korah, H; Negus, SS; Perekopskiy, D; Shaham, Y; Thomas, S | 1 |
| Devi, LA; Fakira, AK; Kennedy, PJ | 1 |
| Kiyatkin, EA | 1 |
1 review(s) available for oxycodone and Anoxia, Brain
| Article | Year |
|---|---|
Respiratory depression and brain hypoxia induced by opioid drugs: Morphine, oxycodone, heroin, and fentanyl.
Topics: Analgesics, Opioid; Animals; Brain; Fentanyl; Heroin; Humans; Hypoxia, Brain; Morphine; Oxycodone; Rats; Respiratory Insufficiency | 2019 |
2 other study(ies) available for oxycodone and Anoxia, Brain
| Article | Year |
|---|---|
In a Rat Model of Opioid Maintenance, the G Protein-Biased Mu Opioid Receptor Agonist TRV130 Decreases Relapse to Oxycodone Seeking and Taking and Prevents Oxycodone-Induced Brain Hypoxia.
Topics: Analgesics, Opioid; Animals; Extinction, Psychological; Female; GTP-Binding Proteins; Humans; Hypoxia, Brain; Male; Oxycodone; Rats; Receptors, Opioid, mu; Recurrence; Self Administration; Spiro Compounds; Thiophenes | 2020 |
Novel Application for G Protein-Biased Mu Opioid Receptor Agonists in Opioid Relapse Prevention.
Topics: Analgesics, Opioid; Animals; GTP-Binding Proteins; Hypoxia, Brain; Oxycodone; Rats; Receptors, Opioid, mu; Recurrence; Secondary Prevention; Spiro Compounds; Thiophenes | 2020 |